Peerbridge Health

Peerbridge Health develops an ambulatory ECG system with AI-enabled cardiac diagnostics, providing a platform that captures high-fidelity signals and transforms complex data into decision-ready insights. The company offers an FDA-cleared wearable device that integrates into existing clinical workflows, enabling earlier detection and proactive management of cardiac conditions. Founded in 2012 and headquartered in New York City, Peerbridge Health has raised approximately $66.1M in Series B funding from investors including Ascent Biomedical Ventures, Northwell, Kinled Holding, Fine Day Ventures, and HealthX Ventures. The company's wearable ECG technology enables continuous remote cardiac monitoring with clinical-grade accuracy, addressing the need for accessible arrhythmia detection and cardiac event monitoring outside hospital settings, supporting the shift toward value-based care and preventive cardiology.